Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2012 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori to Webcast Year End Financial Results March 8

SAN DIEGO, CA--(Marketwire - Feb 23, 2012) - Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its fourth quarter and year end financial results and business update on Thursday,...
January 30, 2012 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA

SAN DIEGO, CA--(Marketwire - Jan 30, 2012) - Cytori Therapeutics (NASDAQ: CYTX) has received an Investigational Device Exemption (IDE) approval from the U.S. FDA to begin the ATHENA trial. ATHENA...
January 24, 2012 07:00 ET | Source: Cytori Therapeutics, Inc.

Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function

SAN DIEGO, CA--(Marketwire - Jan 24, 2012) - Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of previously reported six-month outcomes from APOLLO, the Company's European...
January 05, 2012 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori Announces Presentations at Biotech Showcase on Jan 9th and 10th

SAN DIEGO, CA--(Marketwire - Jan 5, 2012) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) will webcast their corporate presentation at the Biotech Showcase at 4:00 PM PT on Monday, January 9 in San...
December 19, 2011 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System

SAN DIEGO, CA--(Marketwire - Dec 19, 2011) - Cytori Therapeutics (NASDAQ: CYTX) filed its Investigational Device Exemption (IDE) application to begin a clinical trial of the Company's...
November 30, 2011 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori's Celution(R) One Receives European CE Mark Approval

SAN DIEGO, CA--(Marketwire - Nov 30, 2011) - Cytori's (NASDAQ: CYTX) Celution® One System, the next-generation device of the Company's Celution® platform, has been granted CE Mark...
November 28, 2011 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori Therapeutics Announces Participation in the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

SAN DIEGO, CA--(Marketwire - Nov 28, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will present at the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum on December 1. In addition, CEO...
November 10, 2011 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori to Webcast Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011

SAN DIEGO, CA--(Marketwire - Nov 10, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) will webcast their corporate presentation at the Lazard Capital Markets 8th Annual Healthcare Conference at...
November 03, 2011 16:05 ET | Source: Cytori Therapeutics, Inc.

Cytori Reports Third Quarter Business Update and Financial Results

SAN DIEGO, CA--(Marketwire - Nov 3, 2011) - Cytori Therapeutics (NASDAQ: CYTX) today is reporting its third quarter 2011 business update and financial results. Product revenues for the third...
October 26, 2011 08:00 ET | Source: Cytori Therapeutics, Inc.

Cytori to Webcast Third Quarter Financial Results November 3

SAN DIEGO, CA--(Marketwire - Oct 26, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and quarterly business update on Thursday,...